Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: A comprehensive review of reported cases

Neurosurgical Focus

Volumn 36, Issue 1, 2014, Pages

  Kennedy, Benjamin C ^a   McDowell, Michael M ^a   Yang, Peter H ^a   Wilson, Caroline M ^a   Li, Sida ^a   Hankinson, Todd C ^b   Feldstein, Neil A ^a   Anderson, Richard C E ^a  

^a Department of Medicine   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

Encephaloduroarteriosynangiosis; Moyamoya disease; Moyamoya syndrome; Pediatric; Sickle cell anemia

Indexed keywords

ADOLESCENT; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ISCHEMIA; BRAIN VEIN; CEREBROVASCULAR ACCIDENT; CHILD; COHORT ANALYSIS; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METHODOLOGY; MOYAMOYA DISEASE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; RADIOGRAPHY; SICKLE CELL ANEMIA; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ANEMIA, SICKLE CELL; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CEREBRAL VEINS; CHILD; COHORT STUDIES; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MOYAMOYA DISEASE; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; STROKE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84891894468     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2013.10.FOCUS13405     Document Type: Article

References (40)

1. Adams RJ, McKie VC, Carl EM, Nichols FT, Perry R, Brock K, et al: Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 42: 699-704, 1997
2. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 339:5-11, 1998
3. Adams RJ, Pavlakis S, Roach ES: Sickle cell disease and stroke: primary prevention and transcranial Doppler. Ann Neurol 54: 559-563, 2003
4. Bernaudin F, Verlhac S, Coïc L, Lesprit E, Brugières P, Reinert P: Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler. Pediatr Radiol 35:242-248, 2005
5. Bulas DI, Jones A, Seibert JJ, Driscoll C, O'Donnell R, Adams RJ: Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation. Pediatr Radiol 30:733-738, 2000
6. Dobson SR, Holden KR, Nietert PJ, Cure JK, Laver JH, Disco D, et al: Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 99:3144-3150, 2002
7. Dusick JR, Gonzalez NR, Martin NA: Clinical and angiographic outcomes from indirect revascularization surgery for Moyamoya disease in adults and children: a review of 63 procedures. Neurosurgery 68:34-43, 2011
8. el-Fiki M, Chater NL, Weinstein PR: Results of extracranialintracranial arterial bypass for bilateral carotid occlusion. J Neurosurg 63:521-525, 1985
9. Fryer RH, Anderson RC, Chiriboga CA, Feldstein NA: Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure. Pediatr Neurol 29:124-130, 2003
10. Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T: Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 67:273-282, 2007
11. Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T: Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 71:442-447, 2009
12. Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T: Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranialintracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I] iodoamphetamine single-photon emission computed tomography. Neurosurgery 68:957-965, 2011
13. Fujita K, Tamaki N, Matsumoto S: Surgical treatment of moyamoya disease in children: which is more effective procedure, EDAS or EMS? Childs Nerv Syst 2:134-138, 1986
14. Fukui M: Current state of study on moyamoya disease in Japan. Surg Neurol 47:138-143, 1997
15. Garza-Mercado R: Pseudomoyamoya in sickle cell anemia. Surg Neurol 18:425-431, 1982
16. Hankinson TC, Bohman LE, Heyer G, Licursi M, Ghatan S, Feldstein NA, et al: Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis. J Neurosurg Pediatr 1: 211-216, 2008
17. Houkin K, Nakayama N, Kuroda S, Ishikawa T, Nonaka T: How does angiogenesis develop in pediatric moyamoya disease after surgery? A prospective study with MR angiography. Childs Nerv Syst 20:734-741, 2004
18. Hsieh MM, Fitzhugh CD, Tisdale JF: Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now. Blood 118:1197-1207, 2011
19. Jordan LC, Casella JF, DeBaun MR: Prospects for primary stroke prevention in children with sickle cell anaemia. Br J Haematol 157:14-25, 2012
20. Matsushima T, Inoue TK, Suzuki SO, Inoue T, Ikezaki K, Fukui M, et al: Surgical techniques and the results of a frontotemporo-parietal combined indirect bypass procedure for children with moyamoya disease: a comparison with the results of encephalo-duro-arterio-synangiosis alone. Clin Neurol Neurosurg 99 (Suppl 2):S123-S127, 1997
21. Matsushima Y, Aoyagi M, Fukai N, Tanaka K, Tsuruoka S, Inaba Y: Angiographic demonstration of cerebral revascularization after encephalo-duro-arterio-synangiosis (EDAS) performed on pediatric moyamoya patients. Bull Tokyo Med Dent Univ 29:7-17, 1982
22. Meena SS, Ramkumar TV, Sharma S, Aneja S, Kumar A: Moyamoya syndrome associated with severe iron deficiency anemia in a young child. Pediatr Hematol Oncol 29:368-371, 2012
23. Merkel KH, Ginsberg PL, Parker JC Jr, Post MJ: Cerebrovascular disease in sickle cell anemia: a clinical, pathological and radiological correlation. Stroke 9:45-52, 1978
24. Mesiwala AH, Sviri G, Fatemi N, Britz GW, Newell DW: Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with moyamoya disease in the US. Neurosurg Focus 24(2):E15, 2008
25. Miyamoto S, Akiyama Y, Nagata I, Karasawa J, Nozaki K, Hashimoto N, et al: Long-term outcome after STA-MCA anastomosis for moyamoya disease. Neurosurg Focus 5(5):E5, 1998
26. Moschovi M, Psychou F, Menegas D, Tsangaris GT, Tzortzatou-Stathopoulou F, Nicolaidou P: Hodgkin's disease in a child with sickle cell disease treated with hydroxyurea. Pediatr Hematol Oncol 18:371-376, 2001 (Erratum in Pediatr Hematol Oncol 24:651, 2007)
27. Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, et al: Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 39:2644-2691, 2008
28. Ross IB, Shevell MI, Montes JL, Rosenblatt B, Watters GV, Farmer JP, et al: Encephaloduroarteriosynangiosis (EDAS) for the treatment of childhood moyamoya disease. Pediatr Neurol 10:199-204, 1994
29. Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, RockoffMA: Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 100 (2 Suppl Pediatrics):142-149, 2004
30. Seidman C, Kirkham F, Pavlakis S: Pediatric stroke: current developments. Curr Opin Pediatr 19:657-662, 2007
31. Smith ER, McClain CD, Heeney M, Scott RM: Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Neurosurg Focus 26(4):E10, 2009
32. Smith ER, Scott RM: Progression of disease in unilateral moyamoya syndrome. Neurosurg Focus 24(2):E17, 2008
33. Smith ER, Scott RM: Surgical management of moyamoya syndrome. Skull Base 15:15-26, 2005
34. Steinberg MH, Lu ZH, Barton FB, Terrin ML, Charache S, Dover GJ: Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Blood 89:1078-1088, 1997
35. Stricker RB, Linker CA, Crowley TJ, Embury SH: Hematologic malignancy in sickle cell disease: report of four cases and review of the literature. Am J Hematol 21:223-230, 1986
36. Takeuchi S, Ishii R, Tsuchida T, Tanaka R, Kobayashi K, Ito J: Cerebral hemodynamics in patients with moyamoya disease. A study of the epicerebral microcirculation by fluorescein angiography. Surg Neurol 21:333-340, 1984
37. Tripathi P, Tripathi V, Naik RJ, Patel JM: Moya Moya cases treated with encephaloduroarteriosynangiosis. Indian Pediatr 44:123-127, 2007
38. Vernet O, Montes JL, O'Gorman AM, Baruchel S, Farmer JP: Encephaloduroarterio-synangiosis in a child with sickle cell anemia and moyamoya disease. Pediatr Neurol 14:226-230, 1996
39. Webb J, Kwiatkowski JL: Stroke in patients with sickle cell disease. Expert Rev Hematol 6:301-316, 2013
40. Weinstein PR, Rodriguez y Baena R, Chater NL: Results of extracranial-intracranial arterial bypass for intracranial internal carotid artery stenosis: review of 105 cases. Neurosurgery 15:787-794, 1984